L aryngopharyngeal reflux (LFR) is the backflow of gastric contents that pass through the upper esophageal sphincter and enter into the laryngopharynx. Although it is similar to gastroesophageal reflux disease (GERD), which is defined as gastric contents escaping back into the esophagus, it differs concerning symptoms and signs. While retrosternal burning and regurgitation are typical symptoms of GERD, symptoms such as hoarseness, cough, dysphagia, and globus pharyngeus are at the forefront.\[[@ref1],[@ref2]\] Therefore, the referral rates of patients with reflux symptoms to the otolaryngology clinics have increased significantly in recent years.\[[@ref3]\] LFR is present in many etiologies of laryngeal disease, such as reflux laryngitis, subglottic stenosis, laryngeal carcinoma, laryngeal granuloma, contact ulcer and vocal nodule.\[[@ref4],[@ref5]\] Given that these symptoms and signs of larynx and pharynx are nonspecific and factors, such as smoking, infection, allergy and poor voice hygiene, may play a role in the etiology, the diagnosis of LFR becomes difficult.

The 24-hour pH monitoring used in the diagnosis of reflux is the gold standard. Its practical use is not very common in the diagnosis of LFR because its sensitivity is not as high as in GERD and it is an invasive test.\[[@ref6]\] The proton pump inhibitor (PPI), which is generally accepted in the treatment of antireflux, is applied empirically at the first stage. There is no standard protocol, as there are different opinions regarding the duration and dosage of treatment. In our study, the effectiveness of one-month empirical lansoprazole treatment on laryngopharyngeal reflux symptoms, endoscopic larynx findings and gastroesophageal reflux symptoms was investigated.

Methods {#sec1-2}
=======

In our study, 67 patients who presented to the otorhinolaryngology outpatient clinic and had LFR-related symptoms for at least three months were prospectively examined. Patients receiving antireflux therapy, the patients with upper respiratory tract infection, allergic symptoms, systemic disease and smokers were not included in this study. The patients' complaints were evaluated with the 11-item LFR symptom scoring questionnaire, including symptoms of laryngeal pain, sore throat, expectoration, postnasal discharge, need for throat clearing, dysphonia, vocal fatigue, cough, globus sensation, dysphagia and halitosis.

Patients rated their severity from zero to three according to the Likert-type scale as: 0: no symptoms), 1: mild (minimal awareness of symptoms, easily tolerated), 2: moderate (obvious awareness, disturbing but tolerable), 3: severe (difficult to tolerate, preventing daily activities)\].\[[@ref2]\] The complaints of GERD, including burning in the chest, bloating in the abdomen, feeling of heaviness after eating, throat burning. The desire to rub the chest, feeling sick and feeling of fullness in the throat after eating, feeling of throat pain after eating, bitter water coming into the throat, burping and chest pain while bending were questioned using The 12-item Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease (FSSG) questionnaire. Symptoms were scored from zero to four (0: none, 1: rare, 2: sometimes, 3: frequent, 4: always).\[[@ref7]\]

The laryngeal findings were evaluated by the same specialist blinded to the clinical condition of the patient. Using a rigid endoscope with a 70° rigid lens, the posterior larynx, interaritenoid region and arytenoids were evaluated separately for edema, erythema and nodular appearance. The findings were graded and scored from mildest to severe. (0: none, 1: mild, 2: moderate, 3: severe). Patients received a single dose of 30 mg lansoprozole consumed on an empty stomach, for one month. Suggestions for avoiding reflux-enhancing foods, using high pillows while sleeping, and not feeding before sleep were made. LFR and GERD symptoms and laryngeal findings were evaluated again with the same methods after treatment. Data before and after treatment were compared statistically. Our study was approved by the ethics committee (Date, 04.09.2009; decision no. 09-25). Informed consent was obtained from all patients.

Statistical evaluation was performed using SPSS 22.0 program. Continuous variables were expressed as mean±standard deviation and categorical variables as percentages. Before and after the treatment, LFR symptoms and endoscopic larynx findings, GERD symptoms were evaluated using the multi-eyed chi-square test or McNemar Test. FSSG score totals before and after treatment were evaluated with Wilcoxon Signed Ranks Test. In all statistical measurements, p\<0.05 was considered the level of statistical significance.

Results {#sec1-3}
=======

In this study, eleven of the patients were male (16.4%), and 56 were female (83.6%). Patients' ages ranged from 18 to 70 (mean 44.2±11.9) years. LFR symptom scores before and after treatment are summarized in [Table 1](#T1){ref-type="table"}. All LFR symptom scores showed a statistically significant improvement after treatment. Regardless of the severity of the symptoms, the most common symptoms were dysphonia and vocal fatigue (86.6%) and the least common symptom was halitosis (49.3%). While the symptom that improved mostly with treatment was sound fatigue, the symptom of throat-clearing showed the least improvement ([Table 1](#T1){ref-type="table"}).

###### 

Comparison of pre- and post-treatment LFR symptoms

  LFR Symptoms               Severity   Pre-treatment   Post-treatment   p             
  -------------------------- ---------- --------------- ---------------- ------ ------ ---------
  Throat pain                No         12              17.9             28     41.8   \<0.001
  Mild                       27         40.3            31               46.3          
  Moderate                   17         25.4            5                7.5           
  Severe                     11         16.4            3                4.5           
  Sore throat                No         12              17.9             21     31.3   0.016
  Mild                       19         28.4            36               53.7          
  Moderate                   30         44.8            7                10.4          
  Severe                     6          9               3                4.5           
  Expectoration              No         22              32.8             29     43.3   \<0.001
  Mild                       20         29.9            22               32.8          
  Moderate                   13         19.4            13               19.4          
  Severe                     12         17.9            3                4.5           
  Postnasal discharge        No         29              44.3             36     53.7   \<0.001
  Mild                       14         20.9            16               23.9          
  Moderate                   16         23.9            12               17.9          
  Severe                     8          11.9            3                4.5           
  Need for throat clearing   No         11              16.4             17     25.4   \<0.001
  Mild                       15         22.4            30               44.8          
  Moderate                   17         25.4            15               22.4          
  Severe                     24         35.8            5                7.5           
  Dysphonia                  No         9               13.4             28     41.8   \<0.001
  Mild                       22         32.8            26               38.8          
  Moderate                   24         35.8            12               17.9          
  Severe                     12         17.9            1                1.5           
  Vocal fatigue              No         9               13.4             29     43.3   0.002
  Mild                       28         41.8            25               37.3          
  Moderate                   23         34.3            10               14.9          
  Severe                     7          10.4            3                4.5           
  Coughing                   No         19              28.4             33     49.3   0.002
  Mild                       23         34.3            30               44.8          
  Moderate                   17         25.4            4                6             
  Severe                     8          11.9            \--              \--           
  Globus                     No         11              16.4             19     28.4   0.008
  Mild                       12         17.9            35               52.2          
  Moderate                   27         40.3            11               16.4          
  Severe                     17         25.4            2                3             
  Dysphagia                  No         23              34.3             30     44.8   \<0.001
  Mild                       21         31.3            29               43.3          
  Moderate                   16         23.9            7                10.4          
  Severe                     7          10.4            1                1.5           
  Halitosis                  No         33              49.3             40     59.7   \<0.001
  Mild                       18         26.9            16               23.9          
  Moderate                   9          13.4            9                13.4          
  Severe                     7          10.4            2                3             

A statistically significant improvement with treatment was seen endoscopically in the nodular appearance of the posterior larynx, interarytenoid region and arytenoids. Although there was no improvement in erythema in all three regions with treatment, there was a statistically significant regression in edema of the posterior larynx and interarytenoid region. There was no significant improvement in arytenoid edema ([Table 2](#T2){ref-type="table"}).

###### 

Comparison of the endoscopic findings of the larynx before and after treatment

  Endoscopic findings of the larynx   Severity   Pre-treatment   Post-treatment   p              
  ----------------------------------- ---------- --------------- ---------------- ------- ------ ---------
  Posterior larynx                    No         3               4.5              26      38.8   0.02
  Mild                                23         34.3            37               55.2           
  Edema                               Moderate   37              55.2             4       6.0    
  Severe                              4          6.0             \--              \--            
  Erythema                            No         2               3                28      41.8   0.9
  Mild                                18         26.9            34               50.7           
  Moderate                            44         65.7            4                6.0            
  Severe                              3          4.5             1                1.5            
  Nodular appearance                  No         40              59.7             56      83.6   0.006
  Mild                                18         26.9            10               14.9           
  Moderate                            7          10.4            1                1.5            
  Severe                              2          3.0             \--              \--            
  İnteraryternoid region                                                                         
  Edema                               No         1               1.5              22      32.8   0.002
  Mild                                23         34.3            38               56.7           
  Moderate                            37         55.2            7                10.4           
  Severe                              6          9.0             \--              \--            
  Erythema                            No         1               1.5              21      31.3   0.055
  Mild                                20         29.9            42               62.7           
  Moderate                            43         64.2            4                6.0            
  Severe                              3          4.5             \--              \--            
  Nodular appearance                  No         41              61.2             61      91.0   \<0.001
  Mild                                20         29.9            6                9.0            
  Moderate                            6          9.0             \--              \--            
  Severe                              \-\--      \-\--           \--              \--            
  Arytenoids                                                                                     
  Edema                               No         1               1.5              18      26.9   0.746
  Mild                                26         38.8            42               62.7           
  Moderate                            35         52.2            7                10.4           
  Severe                              5          7.5             \--              \--            
  Erythema                            No         1               1.5              19      28.4   0.51
  Mild                                26         38.8            43               64.2           
  Moderate                            36         53.7            5                7.5            
  Severe                              4          6.0             \-\--            \--            
  Nodular appearance                  No         57              85.1             63      94.0   0.001
  Mild                                8          11.9            4                6.0            
  Moderate                            2          3.0             \-\--            \-\--          
  Severe                              \-\--      \--             \-\--            \-\--          

The FSSG scores before and after treatment are separately summarized in [Table 3](#T3){ref-type="table"}. When the total scores were compared, the value of 21.9±8.4 before treatment regressed to 4.6±7.5 after treatment. When GERD symptom scores were examined separately, any significant change was not observed only in the complaint of feeling sick after eating. Regardless of the severity of the symptoms, the most common symptom was the presence of brackish water in the throat (86.6%) and the least common symptom was the desire to rub the chest (53.7%). While the symptom that improved the most with treatment was throat burning after eating, the symptom with the least improvement was a sense of food while swallowing (globus sensation) ([Table 3](#T3){ref-type="table"}).

###### 

Comparison of pre and post-treatment FSSG scores

  FSSG SCORES                         Severity   Pre-treatment   Post-treatment   p             
  ----------------------------------- ---------- --------------- ---------------- ------ ------ ---------
  Burning sensation on the chest      No         12              17.9             20     29.9   \<0.001
  Mild                                11         16.4            18               26.9          
  Moderate                            23         34.3            18               26.9          
  Severe                              14         20.9            11               16.4          
  Extremely severe                    7          10.4            \--              \--           
  Bloating                            No         11              16.4             19     28.4   0.001
  Mild                                9          13.4            17               25.4          
  Moderate                            15         22.4            22               32.8          
  Severe                              22         32.8            6                9             
  Extremely severe                    10         14.9            3                4.5           
  A sense of heaviness after eating   No         11              16.4             17     25.4   0.005
  Mild                                3          4.5             16               23.9          
  Moderate                            23         34.3            21               31.3          
  Severe                              24         35.8            9                13.4          
  Extremely severe                    6          9               4                6             
  The desire to rub the chest         No         31              46.3             40     59.7   0.01
  Mild                                6          9               8                11.9          
  Moderate                            15         22.4            13               19.4          
  Severe                              15         22.4            6                9             
  Extremely severe                    \--        \--             \--              \--           
  Feeling sick after eating           No         18              26.9             25     37.3   0.06
  Mild                                11         16.4            17               25.4          
  Moderate                            16         23.9            16               23.9          
  Severe                              16         23.9            5                7.5           
  Extremely severe                    6          9               4                6             
  Throat burning after eating         No         19              28.4             29     43.3   0.006
  Mild                                6          9               14               20.9          
  Moderate                            22         32.8            16               23.9          
  Severe                              15         22.4            7                10.4          
  Extremely severe                    5          7.5             1                1.5           
  Throat pain after the meal          No         10              14.9             22     32.8   0.01
  Mild                                10         14.9            11               16.4          
  Moderate                            23         34.3            23               34.3          
  Severe                              19         28.4            6                9             
  Extremely severe                    5          7.5             5                7.5           
  Sense of fullness while eating      No         22              32.8             30     44.8   0.02
  Mild                                6          9               16               23.9          
  Moderate                            20         29.9            14               20.9          
  Severe                              15         22.4            4                6             
  Extremely severe                    4          6               3                4.5           
  Globus sensation when swallowing    No         14              20.9             15     22.4   0.04
  Mild                                3          4.5             10               14.9          
  Moderate                            23         34.3            29               43.3          
  Severe                              16         23.9            9                13.4          
  Extremely severe                    11         16.1            4                6             
  Brackish water in the throat        No         9               13.4             13     19.4   0.03
  Mild                                8          11.9            17               25.4          
  Moderate                            26         38.8            28               41.8          
  Severe                              19         28.4            8                11.9          
  Extremely severe                    5          7.5             1                1.5           
  Burping                             No         18              26.9             23     34.3   \<0.001
  Mild                                5          7.5             21               31.3          
  Moderate                            22         32.8            15               22.4          
  Severe                              19         28.4            8                11.9          
  Extremely severe                    3          4.5             \--              \--           
  Chest pain when bending forward     No         29              43.3             36     53.7   0.004
  Mild                                4          6               12               17.9          
  Moderate                            16         23.9            16               23.9          
  Severe                              15         22.4            2                3             
  Extremely severe                    3          4.5             1                1.5           

Discussion {#sec1-4}
==========

The backward escape of gastric contents from the stomach into the laryngopharyngeal region is defined as LFR. Although its mechanism has not been fully elucidated, it is argued that symptoms occur due to the dysfunction of the upper esophageal sphincter.\[[@ref8]\] Up to 10% of patients presenting to the otolaryngology outpatient clinics have symptoms associated with LFR.\[[@ref1]\] In our study, sore throat, laryngeal pain, expectoration, postnasal discharge, the need for throat clearing, dysphonia, vocal fatigue, cough, globus sensation, dysphagia and halitosis are frequently encountered among these symptoms. Although the presence of related symptoms and characteristic laryngeal findings are significant for the diagnosis of LFR, many researchers argue that laryngeal and pharyngeal findings can be very diverse.\[[@ref9]\]

The diagnosis of LFR becomes more difficult, considering that the signs and symptoms can develop due to reflux, as well as other causes, such as smoking, allergy, asthma, viral disease and voice misuse.

GERD is related to multifactorial causes such as disruption of the antireflux barrier, esophageal clearance and esophageal mucosal resistance due to the temporary relaxation of the lower esophageal sphincter.\[[@ref10]\] The differing features of the laryngeal mucosa and lower esophageal mucosa also differentiate the effects of reflux. Thus, the symptoms and signs are also different. Therefore, the relationship of LFR with GERD has not been fully revealed. LFR signs and symptoms in patients diagnosed with reflux esophagitis by esophagogastroduodenoscopy have yielded different results in many studies.\[[@ref11]-[@ref13]\] In our study, LFR and GERD symptoms were evaluated separately, without comparing them.

The reliability of 24-hour dual-probe Ph monitoring, which is the gold standard in the diagnosis of acid reflux LFR, is debatable because of its invasiveness and lower sensitivity.\[[@ref14]\] Thus, the positivity of symptoms, laryngeal findings, and regression of these values with empirical PPI treatment are considered more valuable in the diagnosis of LFR. Lack of laryngeal symptoms and signs with antireflux therapy suggests that the etiology may depend on other reflux components other than the presence of gastric acid. According to the studies performed, laryngeal damage due to LFR can also be induced by pepsin and bile acids in addition to gastric acid.\[[@ref15],[@ref16]\]

Today, the widely accepted approach in the empirical management of LFR and GERD is PPI treatment applied twice daily for two or three months.\[[@ref17]\] In GERD, typical reflux symptoms, such as a burning sensation in the chest, regress with antireflux therapy, while the response to treatment in LFR is not so obvious and varies much from patient to patient. According to some researchers, higher dose and longer-term antireflux treatment are required in LFR than GERD.\[[@ref18]\] If there is no response to appropriate empirical treatment, instead of increasing the dose or extending the duration of treatment, it is necessary to review the diagnosis by considering the multifactorial physiopathology of reflux.\[[@ref19]\]

In our study, we administered a single dose of empirical 30 mg lansoprazole treatment for one month to investigate the short-term results of empirical therapy. Significant improvement was observed in all symptoms of LFR and symptoms of GERD other than feeling sick after eating. There was a significant decrease in the total GSFS score after treatment.

Regarding endoscopic findings of the larynx, we could not achieve satisfactory results compared to symptoms. Although there was a significant decrease in the nodular appearance of the larynx, we could not detect a statistically significant improvement in erythema, but we observed a decrease in the severity of the symptoms.

In their study, Chun et al. applied antireflux therapy by combining six and 12 weeks of PPI alone or together with a prokinetic agent. They found more improvement in endoscopic findings of the larynx after long-term treatment compared to the short-term.\[[@ref20]\] In addition, there are studies in which the same protocol was applied as in our study, and significant improvement was observed in all of the laryngeal findings.\[[@ref21]\] The absence of a complete improvement in all symptoms and findings in the literature indicates that the search for the definitive treatment of reflux will continue.

As a result, different results in the literature make it difficult for us to establish a clear approach to the symptoms and signs of LFR and its relation to GERD. There is a need for a more detailed investigation of the multifactorial physiopathology of reflux, as well as studies with a higher number of cases regarding treatment time and combined approaches.
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